Skip to content

Catalyst Pharmaceutical CPRX Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin86%+0.8pp85.2%-0.5pp85.7%-0.1pp85.8%-0.3pp86.1%+0.1pp
Operating margin44.8%+1.1pp43.8%-1.0pp44.8%+1.2pp43.6%+0.3pp43.3%+3.6pp
Net margin37.1%+0.7pp36.4%-1.2pp37.6%+0.3pp37.4%+0.4pp36.9%+3.6pp
Returns
Return on equity24.5%-1.0pp25.5%-2.0pp27.5%-1.0pp28.5%-0.6pp29.1%-0.3pp
Return on invested capital83.9%-0.6pp84.5%-2.1pp86.6%+2.2pp84.4%+9.4pp75%+11.7pp
Efficiency
Asset turnover0.6×0.0×0.6×0.0×0.6×0.0×0.7×0.0×0.7×-0.1×
Liquidity
Current ratio7.1×+1.0×6.1×-0.5×6.6×-0.1×6.7×+0.6×6.1×+1.0×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Net debt / EBITDA-2.5×-0.1×-2.4×-0.1×-2.3×0.0×-2.3×-0.2×-2.1×+0.1×
Per Share
Book value per share$7.98+6.4%$7.50+3.6%$7.24+7.9%$6.71+7.3%$6.26+7.4%
Valuation
Market capitalization$3.02B+5.4%$2.87B+19.0%$2.41B-10.4%$2.69B-8.6%$2.95B+18.3%
Price / earnings13.7×+0.3×13.4×+2.3×11.1×-1.8×12.9×-2.0×14.9×-0.3×
Price / sales5.1×+0.2×4.9×+0.7×4.2×-0.7×4.8×-0.7×5.5×+0.4×
Price / book0.0×+0.4×2.6×-0.5×3.1×-0.6×3.7×+0.3×
EV / EBITDA7.4×+0.1×7.3×+1.5×5.8×-1.4×7.3×-1.5×8.8×+0.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Catalyst Pharmaceutical's profit margins?
Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
Where do Catalyst Pharmaceutical's ratios come from?
Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.